Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Kraft Heinz
KHC
$32.4B
| $15.9M | 0.03% |
218,800
-160,100
| -42% | -$11.8M |
|
677
Zebra Technologies
ZBRA
$13.5B
| $15.9M | 0.03% |
228,331
+186,200
| +442% | +$14M |
|
678
Expedia Group
EXPE
$35.5B
| $15.9M | 0.03% |
127,854
-17,980
| -12% | -$2.28M |
|
679
Matsons
MATX
$6.15B
| $15.8M | 0.03% |
371,800
+45,900
| +14% | +$2.14M |
|
|
FUR
680
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $15.8M | 0.03% |
1,219,924
+55,000
| +5% | +$767K |
|
|
EZCH
681
DELISTED
EZCHIP SEMICONDUCTOR LIMITED ORD SHS (IL)
EZCH
| $15.8M | 0.03% |
639,619
+357,719
| +127% | +$8.8M |
|
|
VAR
682
DELISTED
Varian Medical Systems, Inc.
VAR
| $15.8M | 0.03% |
222,602
-102,178
| -31% | -$7.06M |
|
683
Stanley Black & Decker
SWK
$14.6B
| $15.7M | 0.03% |
+147,462
| New | +$15.5M |
|
684
Golar LNG
GLNG
$4.95B
| $15.7M | 0.03% |
994,392
+425,058
| +75% | +$10.9M |
|
685
Ralph Lauren
RL
$22.5B
| $15.7M | 0.03% |
140,800
-133,000
| -49% | -$15.8M |
|
686
Lithia Motors
LAD
$8.17B
| $15.6M | 0.03% |
+146,684
| New | +$16.9M |
|
|
SPPI
687
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $15.6M | 0.03% |
2,591,319
+817,802
| +46% | +$4.68M |
|
688
Ameris Bancorp
ABCB
$5.9B
| $15.6M | 0.03% |
457,900
-28,268
| -6% | -$907K |
|
|
NUVA
689
DELISTED
NuVasive, Inc.
NUVA
| $15.5M | 0.03% |
286,588
+38,200
| +15% | +$1.95M |
|
690
Regal Rexnord
RRX
$13.5B
| $15.5M | 0.03% |
264,300
+95,624
| +57% | +$5.86M |
|
|
RGC
691
DELISTED
Regal Entertainment Group
RGC
| $15.4M | 0.03% |
818,500
-370,700
| -31% | -$7.04M |
|
|
YDKN
692
DELISTED
Yadkin Financial Corporation
YDKN
| $15.4M | 0.03% |
612,796
+82,500
| +16% | +$2M |
|
693
Graham Holdings Company
GHC
$5.23B
| $15.4M | 0.03% |
31,800
+7,000
| +28% | +$3.81M |
|
694
Cohen & Steers
CNS
$4.24B
| $15.4M | 0.03% |
505,900
+25,900
| +5% | +$779K |
|
|
CDR
695
DELISTED
Cedar Realty Trust, Inc
CDR
| $15.4M | 0.03% |
328,788
+16,727
| +5% | +$767K |
|
696
Accuray
ARAY
$29M
| $15.4M | 0.03% |
2,275,523
+278,800
| +14% | +$1.79M |
|
|
PRA
697
DELISTED
ProAssurance
PRA
| $15.3M | 0.03% |
316,200
+82,000
| +35% | +$4.21M |
|
|
SRDX
698
DELISTED
Surmodics
SRDX
| $15.3M | 0.03% |
754,938
+119,900
| +19% | +$2.55M |
|
|
QUNR
699
DELISTED
Qunar Cayman Islands Limited
QUNR
| $15.3M | 0.03% |
290,000
+152,350
| +111% | +$6.59M |
|
|
CSR
700
Centerspace
CSR
$941M
| $15.3M | 0.03% |
219,895
+67,535
| +44% | +$5.26M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.